X-396

· Betta Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for X-396, covering 2020-01-09 to 2023-08-16. Get the full timeline:

Most recent: Clinical Trial Update: X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib [Phase 2]

See pricing